Pharmesis International Ltd. (SGX:BFK)

Pharmesis International Ratios and Metrics

Market cap in millions SGD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	16	18	3	3	3	7
Market Cap Growth	573.89%	573.89%	7.89%	-27.33%	-47.37%	32.56%
Enterprise Value	18	21	5	4	4	7
Last Close Price	0.50	0.57	0.10	0.11	0.15	0.28
PE Ratio	9.65	11.78	-	-	13.89	-
PS Ratio	1.18	1.44	0.32	0.26	0.31	0.69
PB Ratio	1.38	1.58	0.27	0.23	0.27	0.56
P/TBV Ratio	1.62	1.62	0.29	0.25	0.29	0.59
P/FCF Ratio	-	-	2.04	-	41.89
P/OCF Ratio	-	-	1.97	24.90	19.15
EV/Sales Ratio	1.42	1.67	0.56	0.42	0.40	0.78
EV/EBITDA Ratio	24.36	34.91	-	-	8.93	-
EV/EBIT Ratio	47.52	55.85	-	-	19.59	-
EV/FCF Ratio	-22.68	-	-	3.34	-	47.32
Debt / Equity Ratio	0.26	0.26	0.31	0.29	0.28	0.27
Debt / EBITDA Ratio	4.03	4.03	-	-	5.89	-
Debt / FCF Ratio	-	-	-	2.61	-	20.53
Asset Turnover	0.67	0.67	0.50	0.53	0.57	0.51
Inventory Turnover	2.95	2.95	2.24	2.65	3.20	3.02
Quick Ratio	0.79	0.79	0.58	0.82	0.92	0.86
Current Ratio	1.06	1.06	1.09	1.12	1.21	1.14
Return on Equity (ROE)	13.14%	13.14%	-8.82%	-5.42%	3.33%	-9.57%
Return on Assets (ROA)	1.26%	1.26%	-5.17%	-1.66%	0.72%	-2.92%
Return on Capital (ROIC)	1.70%	1.70%	-6.58%	-2.10%	0.88%	-3.51%
Return on Capital Employed (ROCE)	3.30%	3.30%	-	-	1.70%	-
Earnings Yield	9.77%	8.49%	-34.12%	-27.61%	7.20%	-18.00%
FCF Yield	-5.00%	-4.35%	-83.72%	49.05%	-5.71%	2.39%
Buyback Yield / Dilution	-13.08%	-13.08%	-14.85%	-	-	-

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.